Predictive value of tumor-infiltrating lymphocytes combined with tumor-stromal ratio for axillarylymph node metastasis in breast cancer patients - a retrospective cohort study [0.03%]
肿瘤浸润淋巴细胞联合肿瘤间质比预测乳腺癌患者腋窝淋巴结转移的回顾性队列研究
Huan Han,Shuyi Yin,Xin He et al.
Huan Han et al.
Angiomatoid fibrous histiocytoma of the adrenal gland: a clinical and pathological observation of two cases [0.03%]
肾上腺血管瘤样纤维组织细胞瘤的临床和病理观察两例
Li Yang,Li Xiao,Jiandi Li et al.
Li Yang et al.
Background: Angiomatoid fibrous histiocytoma (AFH) is a rare low-grade neoplasm, typically arising in pediatric/adolescent extremity subcutaneous tissues. Adrenal AFH is extremely uncommon, with limited reported cases. In...
Emerging role of histone and non-histone lactylation in metabolic reprogramming of female-specific malignancies [0.03%]
组蛋白和非组蛋白乳酰化的女性特异性恶性肿瘤代谢重编程中的作用机制
Cheng Sun,Dan Hu,Wei Peng et al.
Cheng Sun et al.
Lysine lactylation (Klac), a recently characterized post-translational modification, has emerged as a critical epigenetic regulator in female-prevalent malignancies including breast, ovarian, cervical, and endometrial cancers. Emerging evid...
Non-invasive identification of KRAS mutation in rectal cancer using hybrid intravoxel incoherent motion and diffusion kurtosis model [0.03%]
基于混合亚voxel无序运动和扩散曲率模型的结肠直肠癌非侵入式KRAS突变检测研究
Jie Yuan,Mingrong Yao,Ziyuan Wang et al.
Jie Yuan et al.
Background and purpose: Sarcoma Viral Oncogene Homologue (KRAS) mutation status is a crucial biomarker in rectal cancer as KRAS mutations confer resistance to anti-EGFR targeted therapies and influence chemotherapy select...
Multidisciplinary management and molecular characterization of inferior vena cava leiomyosarcoma: a case report [0.03%]
下腔静脉平滑肌肉瘤的多学科管理及分子特征分析：一例报道
Alessia Pini,Maria Abbondanza Pantaleo,Annalisa Astolfi et al.
Alessia Pini et al.
Leiomyosarcoma of the inferior vena cava (IVC) is a rare and aggressive malignancy, with poor prognosis and no universally accepted treatment protocol. We present the case of a 69-year-old male with an IVC leiomyosarcoma, which extended fro...
Mutational landscape of gastrointestinal stromal tumors using next-generation sequencing of a 73-gene panel [0.03%]
基于下一代测序技术的胃肠道间质瘤73基因检测结果分析
Chang Wang,Baosen Cheng,Shuya Yang et al.
Chang Wang et al.
Purpose: Mutational analysis guides therapeutic decision-making for patients with advanced-stage gastrointestinal stromal tumors (GISTs). Materials and me...
Development and validation of a nomogram model for predicting acute hepatic dysfunction post-intervention in primary hepatocellular carcinoma: a retrospective case-control study [0.03%]
肝细胞癌经导管动脉化疗栓塞术后急性肝功能障碍预测列线图的构建和验证：回顾性病例对照研究
Lu Xu,Linan Du,Jianhua Pan et al.
Lu Xu et al.
Objectives: To identify independent risk factors for acute liver function damage (ALFD) following interventional treatment in hepatocellular carcinoma (HCC) patients and to develop and validate a novel Nomogram predictive...
Oncologic adequacy and outcomes of open, transoral endoscopic, and robotic thyroidectomy for papillary thyroid carcinoma: a propensity score-matched analysis [0.03%]
甲状腺乳头状癌开放式手术、经口内镜和机器人甲状腺切除术的肿瘤学充分性和结局：倾向性匹配分析
Jun Ho Lee,Hongki Gwak
Jun Ho Lee
Background: Transoral thyroidectomy, including transoral endoscopic thyroidectomy vestibular approach (TOETVA) and transoral robotic thyroidectomy (TORT), offers cosmetic advantages over conventional open thyroidectomy (O...
Non-small cell lung carcinoma with co-expression of thyroid transcription factor-1 and p40: a case report and literature review [0.03%]
甲状腺转录因子-1和p40共表达的非小细胞肺癌1例报告及文献复习
Chusheng Wei,Yishan Wang,Weijia Lu et al.
Chusheng Wei et al.
Background: Non-small cell lung carcinoma (NSCLC) with co-expression of thyroid transcription factor-1 and p40 is an extremely rare and diagnostically challenging subtype. These tumors exhibit both glandular and squamous ...
Consensus Molecular Subtypes (CMS) Classification: a progress towards Subtype-Driven treatments in colorectal cancer [0.03%]
共识分子亚型（CMS）分类：走向结直肠癌亚型驱动治疗的一项进展
Akshay Kantha,Doutrina Das,Esha Pai et al.
Akshay Kantha et al.
Background: Colorectal cancer (CRC) is heterogeneous with varied molecular profiles, clinical outcomes, and treatment responses. The Consensus Molecular Subtypes (CMS) classification categorizes CRC into four molecular su...